首页> 外文期刊>International Journal of Nanomedicine >Ectopic chondrogenesis of nude mouse induced by nano gene delivery enhanced tissue engineering technology
【24h】

Ectopic chondrogenesis of nude mouse induced by nano gene delivery enhanced tissue engineering technology

机译:纳米基因递送诱导裸鼠异位软骨形成增强组织工程技术

获取原文
           

摘要

Background: Many techniques and methods have been used clinically to relieve pain from cartilage repair, but the long-term effect is still unsatisfactory. Purpose: The objective of this study was to form an artificial chondroid tissue gene enhanced tissue engineering system to repair cartilage defects via nanosized liposomes. Methods: Cationic nanosized liposomes were prepared and characterized using transmission electron microscope (TEM) and dynamic laser light scattering (DLS). The rat mesenchymal stem cells (rMSCs) were isolated, cultivated, and induced by SRY (Sex-Determining Region Y)-Box 9 (Sox9) via cationic nanosized liposomes. The induced rMSCs were mixed with a thermo-sensitive chitosan hydrogel and subcutaneously injected into the nude mice. Finally, the newly-formed chondroid tissue obtained in the injection parts, and the transparent parts were detected by HE, collagen II, and safranin O. Results: It was found that the presently prepared cationic nanosized liposomes had the diameter of 85.76±3.48 nm and the zeta potential of 15.76±2.1 mV. The isolated rMSCs proliferation was fibroblast-like, with a cultivated confluence of 90% confluence in 5–8 days, and stained positive for CD29 and CD44 while negative for CD34 and CD45. After transfection with cationic nanosized liposomes, we observed changes of cellular morphology and a higher expression of SOX9 compared with control groups, which indicated that rMSCs could differentiate into chondrocyte in vitro. By mixing transfected rMSCs with the thermo-sensitive hydrogel of chitosan in nude mice, chondroid tissue was successfully obtained, demonstrating that rMSCs can differentiate into chondrogenic cells in vivo. Conclusion: This study explored new ways to improve the quality of tissue engineered cartilage, thus accelerating clinical transformation and reducing patient pain.
机译:背景:临床上已使用许多技术和方法来减轻软骨修复的疼痛,但长期效果仍不令人满意。目的:本研究的目的是形成一个人造软骨组织基因增强的组织工程系统,以通过纳米脂质体修复软骨缺损。方法:采用透射电子显微镜(TEM)和动态激光散射(DLS)制备阳离子纳米脂质体并进行表征。分离,培养大鼠间充质干细胞(rMSCs),并通过SRY(性决定区Y)-Box 9(Sox9)经由阳离子纳米级脂质体对其进行诱导。将诱导的rMSC与热敏壳聚糖水凝胶混合,皮下注射到裸鼠中。最后,用注射液,胶原蛋白Ⅱ和番红蛋白O对注射部位形成的新形成的软骨样组织进行了检测。结果:发现目前制备的阳离子纳米脂质体的直径为85.76±3.48 nm。和ζ电位为15.76±2.1 mV。分离的rMSCs增殖是成纤维细胞样的,在5-8天培养的融合度为90%融合度,CD29和CD44染色阳性,而CD34和CD45染色阴性。与对照组相比,阳离子纳米脂质体转染后,我们观察到细胞形态的变化和SOX9的更高表达,这表明rMSCs可以在体外分化为软骨细胞。通过在裸鼠中将转染的rMSCs与壳聚糖的热敏水凝胶混合,可以成功获得软骨样组织,表明rMSCs可以在体内分化为软骨细胞。结论:本研究探索了改善组织工程软骨质量,从而加速临床转化并减轻患者痛苦的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号